Trial Profile
A Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Dec 2018
Price :
$35
*
At a glance
- Drugs Icotinib (Primary)
- Indications Carcinoma; Oesophageal cancer
- Focus Therapeutic Use
- 04 Mar 2015 New trial record